Project Grant R21NS139251
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$228K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Washington, DC 20010, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders provides $853,312 to Creighton University to research a novel therapeutic strategy targeting neuroinflammation for global cerebral ischemia associated with cardiac arrest. The primary objectives are to determine the pathological importance of the TREM1 receptor, elucidate the mechanisms by which...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $224,424 to The Regents of the University of Colorado (doing business as the University of Colorado-Denver) to investigate the role of inflammasome pathways as molecular mediators of age-related differences in brain injury after global cerebral ischemia induced by cardiac...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is providing $220,244 to The Trustees of the University of Pennsylvania to conduct research on using functional brain imaging to detect and predict consciousness recovery in patients with acute brain injury. The key objectives are to: 1) investigate how brain network connectivity...
This $536,617 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to understand the mechanisms of neural regeneration in model organisms. The primary awardee, Oregon Health & Science University, will conduct experiments using planarians and zebrafish to investigate how adult neural stem cells can regenerate neural tissue and restore...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $129,454 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Maryland, Baltimore. The award, effective from December 28, 2024 to April 28, 2025, supports research to define the contributions of neuronal SUR1-TRPM4 expression to chronic seizure activity. Specifically, the project aims to assess the effects of neuron-specific SUR1-TRPM4...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA 93.853 "Extramural Research Programs in the Neurosciences and Neurological Disorders", provides $230,904 to Boston Children's Hospital from January 1, 2025 to December 31, 2029. The award will support research to identify novel genetic causes of infantile epilepsies and evaluate the impact of genetic diagnosis on patient outcomes and families. Key objectives include applying...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is providing $524,243 to Intrinsic Powers, Inc. to develop a portable TMS-EEG device for bedside detection of covert consciousness in patients with disorders of consciousness due to severe brain injury. The key products to be delivered through this 2-year award include: 1) Refinement of the...
The federal Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research aimed at developing a highly personalized approach to thalamic neuromodulation for treating drug-resistant epilepsy. The $256,500 award, spanning from January 1, 2025 to December 31, 2029, will enable the principal investigator at Mayo Clinic to: 1) map...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $400,000.00 in funding to Baylor College of Medicine to investigate the contributions of spreading depolarization (SD) to epilepsy comorbidities and disease progression in Dravet syndrome, a major developmental epileptic encephalopathy. The 5-year project, which began on...
This Project Grant award of $192,500 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to define the contribution of endothelial cell sphingolipid metabolism to outcomes of acute ischemic stroke in mice. The award, effective December 1, 2024, will enable the University of Utah to leverage innovative murine models and novel ceramide biosynthesis...